Brandywine Global Investment Management, LLC Aquestive Therapeutics, Inc. Transaction History

Brandywine Global Investment Management, LLC

$13.5 Billion
Q1 2024

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 11, 2022	SELL	$3.69 - $6.37 $461,309 - $796,351	-125,016 Closed	0 $0
Q3 2021 Nov 12, 2021	SELL	$3.25 - $4.66 $1,300 - $1,864	-400 Reduced 0.32%	125,016 $545,000
Q2 2021 Aug 13, 2021	SELL	$3.29 - $5.21 $35,203 - $55,747	-10,700 Reduced 7.86%	125,416 $498,000
Q1 2021 May 13, 2021	SELL	$4.17 - $6.73 $6,255 - $10,095	-1,500 Reduced 1.09%	136,116 $708,000
Q4 2020 Feb 10, 2021	BUY	$4.65 - $7.79 $2,729 - $4,572	587 Added 0.43%	137,616 $736,000

Q3 2020 Nov 12, 2020	BUY	$4.12 - $9.09 $189,108 - $417,231	45,900 Added 50.37%	137,029 $666,000
Q2 2020 Aug 14, 2020	BUY	$1.84 - $6.44 $3,128 - $10,948	1,700 Added 1.9%	91,129 $443,000
Q1 2020 May 15, 2020	BUY	$1.54 - $6.75 $1,906 - $8,356	1,238 Added 1.4%	89,429 $196,000
Q4 2019 Feb 14, 2020	BUY	$3.06 - $8.78 $74,942 - $215,030	24,491 Added 38.45%	88,191 $532,000
Q2 2019 Aug 14, 2019	BUY	$3.72 - $6.95 $166,284 - $310,665	44,700 Added 235.26%	63,700 $268,000
Q1 2019 May 15, 2019	BUY	$5.74 - $8.05 $109,060 - $152,950	19,000 New	19,000 $132,000

Others Institutions Holding AQST

# of Institutions

105

Shares Held

42.1M

Call Options Held

463K

Put Options Held

431K

Bratton Capital Management, L.P. Fort Worth, TX

9.81M
Shares

$25.5 Million
100.0% of portfolio
Vr Adviser, LLC New York, NY

5.56M
Shares

$14.4 Million
2.03% of portfolio
Vanguard Group Inc Valley Forge, PA

3.24M
Shares

$8.43 Million
0.0% of portfolio
Franklin Resources Inc San Mateo, CA

2.22M
Shares

$5.77 Million
0.0% of portfolio
Laurion Capital Management LP New York, NY

1.55M
Shares

$4.02 Million
0.06% of portfolio

View Full List

About Aquestive Therapeutics, Inc.

Ticker AQST
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 53,350,700
Market Cap $139M
Description
Aquestive Therapeutics, Inc., a pharmaceutical company, focuses on identifying, developing, and commercializing various products to address unmet medical needs in the United States and internationally. The company markets Sympazan, an oral soluble film formulation of clobazam for the treatment of lennox-gastaut syndrome; Suboxone, a sublingual f...

More about AQST

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Brandywine Global Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Brandywine Global Investment Management, LLC with notifications on news.

Account